Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy - a perspective.

Kiuchi MG, Carnagarin R, Matthews VB, Schlaich MP.

Postepy Kardiol Interwencyjnej. 2019;15(4):503-504. doi: 10.5114/aic.2019.90231. Epub 2019 Dec 8. No abstract available.

2.

Low-dose UV radiation before running wheel access activates brown adipose tissue.

Allemann TS, Dhamrait G, Fleury N, Abel T, Hart P, Lucas RM, Matthews VB, Gorman S.

J Endocrinol. 2020 Jan 1. pii: JOE-19-0470.R1. doi: 10.1530/JOE-19-0470. [Epub ahead of print]

PMID:
31905167
3.

Does sympathetic hyperactivity adversely impact on the effect of pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation?

Kiuchi MG, Chen S, Carnagarin R, Matthews VB, Schlaich MP.

Europace. 2019 Dec 3. pii: euz316. doi: 10.1093/europace/euz316. [Epub ahead of print] No abstract available.

PMID:
31793998
4.

Renal denervation for treating congenital long QT syndrome: shortening the QT interval or modulating sympathetic tone?

Kiuchi MG, Chen S, Carnagarin R, Matthews VB, Schlaich MP.

Europace. 2019 Nov 1;21(11):1755-1756. doi: 10.1093/europace/euz251. No abstract available.

PMID:
31603504
5.

The Schlager mouse as a model of altered retinal phenotype.

Herat LY, Magno AL, Kiuchi MG, Jackson KL, Carnagarin R, Head GA, Schlaich MP, Matthews VB.

Neural Regen Res. 2020 Mar;15(3):512-518. doi: 10.4103/1673-5374.266069.

6.

New Molecules for Treating Resistant Hypertension: a Clinical Perspective.

Azzam O, Kiuchi MG, Ho JK, Matthews VB, Gavidia LML, Nolde JM, Carnagarin R, Schlaich MP.

Curr Hypertens Rep. 2019 Sep 10;21(10):80. doi: 10.1007/s11906-019-0978-z. Review.

PMID:
31506798
7.

Effects of sympathetic modulation in metabolic disease.

Carnagarin R, Lambert GW, Kiuchi MG, Nolde JM, Matthews VB, Eikelis N, Lambert EA, Schlaich MP.

Ann N Y Acad Sci. 2019 Oct;1454(1):80-89. doi: 10.1111/nyas.14217. Epub 2019 Aug 19. Review.

PMID:
31424101
8.

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.

Kiuchi MG, Nolde JM, Villacorta H, Carnagarin R, Chan JJS, Lugo-Gavidia LM, Ho JK, Matthews VB, Dwivedi G, Schlaich MP.

Int J Mol Sci. 2019 May 16;20(10). pii: E2430. doi: 10.3390/ijms20102430. Review.

9.

May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia.

Carnagarin R, Fonseca R, Brockman D, Hering D, Matthews VB, Mihailidou A, Reid C, Lee R, Lambert GW, Burrell LM, Sharman JE, Xia X, Poulter NR, Beaney T, Islam SM, Carrington M, Schlaich MP.

Eur Heart J Suppl. 2019 Apr;21(Suppl D):D14-D16. doi: 10.1093/eurheartj/suz052. Epub 2019 Apr 24.

10.

Relevance of Targeting the Distal Renal Artery and Branches with Radiofrequency Renal Denervation Approaches-A Secondary Analysis from a Hypertensive CKD Patient Cohort.

Kiuchi MG, Schlaich MP, Chen S, Villacorta H, Ho JK, Carnagarin R, Matthews VB, Lugon JR.

J Clin Med. 2019 Apr 27;8(5). pii: E581. doi: 10.3390/jcm8050581.

11.

Self-monitoring of blood pressure to guide titration of antihypertensive medication-a new era in hypertension management?

Ho JK, Carnagarin R, Matthews VB, Schlaich MP.

Cardiovasc Diagn Ther. 2019 Feb;9(1):94-99. doi: 10.21037/cdt.2018.08.01. No abstract available.

12.

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease.

Magno AL, Herat LY, Carnagarin R, Schlaich MP, Matthews VB.

Biomedicines. 2019 Mar 13;7(1). pii: E19. doi: 10.3390/biomedicines7010019. Review.

13.

Sympathetic stimulation with norepinephrine may come at a cost.

Herat LY, Schlaich MP, Matthews VB.

Neural Regen Res. 2019 Jun;14(6):977-978. doi: 10.4103/1673-5374.250576. No abstract available.

14.

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation.

Carnagarin R, Kiuchi MG, Ho JK, Matthews VB, Schlaich MP.

Front Neurosci. 2019 Jan 23;12:1058. doi: 10.3389/fnins.2018.01058. eCollection 2018. Review.

15.

Maternal high fat diet compromises survival and modulates lung development of offspring, and impairs lung function of dams (female mice).

Smoothy J, Larcombe AN, Chivers EK, Matthews VB, Gorman S.

Respir Res. 2019 Jan 30;20(1):21. doi: 10.1186/s12931-019-0976-3.

16.

Autonomic Regulation of Glucose Homeostasis: a Specific Role for Sympathetic Nervous System Activation.

Carnagarin R, Matthews VB, Herat LY, Ho JK, Schlaich MP.

Curr Diab Rep. 2018 Sep 19;18(11):107. doi: 10.1007/s11892-018-1069-2. Review.

PMID:
30232652
17.

Long-Term Dietary Nitrate Supplementation Does Not Prevent Development of the Metabolic Syndrome in Mice Fed a High-Fat Diet.

Matthews VB, Hollingshead R, Koch H, Croft KD, Ward NC.

Int J Endocrinol. 2018 Aug 5;2018:7969750. doi: 10.1155/2018/7969750. eCollection 2018.

18.

A cautionary note for researchers treating mice with the neurotransmitter norepinephrine.

Matthews VB, Rudnicka C, Schlaich MP.

Biochem Biophys Rep. 2018 Aug 17;15:103-106. doi: 10.1016/j.bbrep.2018.08.003. eCollection 2018 Sep.

19.

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy.

Herat LY, Matthews VB, Rakoczy PE, Carnagarin R, Schlaich M.

Int J Endocrinol. 2018 Jul 5;2018:9254126. doi: 10.1155/2018/9254126. eCollection 2018. Review.

20.

Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet.

Tan S, Caparros-Martin JA, Matthews VB, Koch H, O'Gara F, Croft KD, Ward NC.

Sci Rep. 2018 Jul 4;8(1):10100. doi: 10.1038/s41598-018-28521-8.

21.

Suitability for catheter-based renal denervation-lessons from 'super-responders'.

Schlaich MP, Carnagarin R, Ho JK, Matthews VB.

J Hypertens. 2018 Jul;36(7):1475-1476. doi: 10.1097/HJH.0000000000001756. No abstract available.

PMID:
29847451
22.

Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production.

Saunders BM, Rudnicka C, Filipovska A, Davies S, Ward N, Hricova J, Schlaich MP, Matthews VB.

Immunol Cell Biol. 2018 Jan;96(1):41-53. doi: 10.1111/imcb.1002. Epub 2017 Nov 23.

PMID:
29359470
23.

Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2.

Matthews VB, Elliot RH, Rudnicka C, Hricova J, Herat L, Schlaich MP.

J Hypertens. 2017 Oct;35(10):2059-2068. doi: 10.1097/HJH.0000000000001434.

PMID:
28598954
24.

ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Weerasekera L, Rudnicka C, Sang QX, Curran JE, Johnson MP, Moses EK, Göring HH, Blangero J, Hricova J, Schlaich M, Matthews VB.

Mediators Inflamm. 2017;2017:7281986. doi: 10.1155/2017/7281986. Epub 2017 Feb 7.

25.

Sub-erythemal ultraviolet radiation reduces metabolic dysfunction in already overweight mice.

Fleury N, Feelisch M, Hart PH, Weller RB, Smoothy J, Matthews VB, Gorman S.

J Endocrinol. 2017 Apr;233(1):81-92. doi: 10.1530/JOE-16-0616. Epub 2017 Feb 2.

PMID:
28154004
26.

Is it time to think about the sodium glucose co-transporter 2 sympathetically?

Elliott RH, Matthews VB, Rudnicka C, Schlaich MP.

Nephrology (Carlton). 2016 Apr;21(4):286-94. doi: 10.1111/nep.12620. Review.

PMID:
26369359
27.

Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance.

Kraakman MJ, Kammoun HL, Allen TL, Deswaerte V, Henstridge DC, Estevez E, Matthews VB, Neill B, White DA, Murphy AJ, Peijs L, Yang C, Risis S, Bruce CR, Du XJ, Bobik A, Lee-Young RS, Kingwell BA, Vasanthakumar A, Shi W, Kallies A, Lancaster GI, Rose-John S, Febbraio MA.

Cell Metab. 2015 Mar 3;21(3):403-16. doi: 10.1016/j.cmet.2015.02.006. Erratum in: Cell Metab. 2016 Mar 8;23(3):563.

28.

Erratum to: Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.

Matthews VB, Åström MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Åkerström T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA.

Diabetologia. 2015 Apr;58(4):854-5. doi: 10.1007/s00125-015-3502-2. No abstract available.

PMID:
25693750
29.

Correction to Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice.

Mubarak A, Hodgson JM, Considine MJ, Croft KD, Matthews VB.

J Agric Food Chem. 2015 Feb 18;63(6):1882. doi: 10.1021/acs.jafc.5b00621. Epub 2015 Feb 9. No abstract available.

PMID:
25665130
30.

Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice.

Lindegaard B, Matthews VB, Brandt C, Hojman P, Allen TL, Estevez E, Watt MJ, Bruce CR, Mortensen OH, Syberg S, Rudnicka C, Abildgaard J, Pilegaard H, Hidalgo J, Ditlevsen S, Alsted TJ, Madsen AN, Pedersen BK, Febbraio MA.

Diabetes. 2013 Sep;62(9):3064-74. doi: 10.2337/db12-1095. Epub 2013 May 13.

31.

Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice.

Mubarak A, Hodgson JM, Considine MJ, Croft KD, Matthews VB.

J Agric Food Chem. 2013 May 8;61(18):4371-8. doi: 10.1021/jf400920x. Epub 2013 Apr 26. Erratum in: J Agric Food Chem. 2015 Feb 18;63(6):1882.

PMID:
23586419
32.

ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α.

Jowett JB, Okada Y, Leedman PJ, Curran JE, Johnson MP, Moses EK, Goring HH, Mochizuki S, Blangero J, Stone L, Allen H, Mitchell C, Matthews VB.

Immunol Cell Biol. 2012 Nov;90(10):966-73. doi: 10.1038/icb.2012.44. Epub 2012 Sep 25.

33.

Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1.

Whitham M, Chan MH, Pal M, Matthews VB, Prelovsek O, Lunke S, El-Osta A, Broenneke H, Alber J, Brüning JC, Wunderlich FT, Lancaster GI, Febbraio MA.

J Biol Chem. 2012 Mar 30;287(14):10771-9. doi: 10.1074/jbc.M111.310581. Epub 2012 Feb 18.

34.

Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice.

Harcourt BE, Forbes JM, Matthews VB.

Nephrology (Carlton). 2012 Mar;17(3):257-62. doi: 10.1111/j.1440-1797.2011.01547.x.

PMID:
22128916
35.

Overcoming insulin resistance with ciliary neurotrophic factor.

Allen TL, Matthews VB, Febbraio MA.

Handb Exp Pharmacol. 2011;(203):179-99. doi: 10.1007/978-3-642-17214-4_9. Review.

PMID:
21484573
36.

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance.

Matthews VB, Allen TL, Risis S, Chan MH, Henstridge DC, Watson N, Zaffino LA, Babb JR, Boon J, Meikle PJ, Jowett JB, Watt MJ, Jansson JO, Bruce CR, Febbraio MA.

Diabetologia. 2010 Nov;53(11):2431-41. doi: 10.1007/s00125-010-1865-y. Epub 2010 Aug 11.

PMID:
20697689
37.

PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.

Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):724-32. doi: 10.1161/ATVBAHA.109.201988.

PMID:
20237330
38.

Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals.

Pedersen BK, Pedersen M, Krabbe KS, Bruunsgaard H, Matthews VB, Febbraio MA.

Exp Physiol. 2009 Dec;94(12):1153-60. doi: 10.1113/expphysiol.2009.048561. Epub 2009 Sep 11. Review.

39.

Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.

Matthews VB, Aström MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerström T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA.

Diabetologia. 2009 Jul;52(7):1409-18. doi: 10.1007/s00125-009-1364-1. Epub 2009 Apr 22. Erratum in: Diabetologia. 2012 Mar;55(3):864. Diabetologia. 2015 Apr;58(4):854-5.

PMID:
19387610
40.

Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression.

Yuen DY, Dwyer RM, Matthews VB, Zhang L, Drew BG, Neill B, Kingwell BA, Clark MG, Rattigan S, Febbraio MA.

Diabetes. 2009 May;58(5):1086-95. doi: 10.2337/db08-0775. Epub 2009 Feb 2.

41.

STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ.

J Clin Invest. 2008 May;118(5):1727-38. doi: 10.1172/JCI34944.

42.

CNTF: a target therapeutic for obesity-related metabolic disease?

Matthews VB, Febbraio MA.

J Mol Med (Berl). 2008 Apr;86(4):353-61. doi: 10.1007/s00109-007-0286-y. Epub 2008 Jan 22. Review.

PMID:
18210031
43.

Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 signaling in liver progenitor cell migration and proliferation.

Yeoh GC, Ernst M, Rose-John S, Akhurst B, Payne C, Long S, Alexander W, Croker B, Grail D, Matthews VB.

Hepatology. 2007 Feb;45(2):486-94.

PMID:
17256754
44.

Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice.

Knight B, Akhurst B, Matthews VB, Ruddell RG, Ramm GA, Abraham LJ, Olynyk JK, Yeoh GC.

J Hepatol. 2007 Jan;46(1):134-41. Epub 2006 Oct 9.

PMID:
17112626
45.

Jekyll and Hyde: evolving perspectives on the function and potential of the adult liver progenitor (oval) cell.

Knight B, Matthews VB, Olynyk JK, Yeoh GC.

Bioessays. 2005 Nov;27(11):1192-202. Review.

PMID:
16237666
46.

Liver stem cells.

Matthews VB, Yeoh GC.

IUBMB Life. 2005 Aug;57(8):549-53. Review.

47.

Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury.

Knight B, Matthews VB, Akhurst B, Croager EJ, Klinken E, Abraham LJ, Olynyk JK, Yeoh G.

Immunol Cell Biol. 2005 Aug;83(4):364-74.

PMID:
16033531
48.

Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.

Matthews VB, Knight B, Tirnitz-Parker JE, Boon J, Olynyk JK, Yeoh GC.

Exp Cell Res. 2005 May 15;306(1):252-63. Epub 2005 Mar 17.

PMID:
15878349
49.

Direct effects of interleukin-6 on liver progenitor oval cells in culture.

Matthews VB, Klinken E, Yeoh GC.

Wound Repair Regen. 2004 Nov-Dec;12(6):650-6.

PMID:
15555057
50.

Genetic manipulations utilizing albumin and alpha-fetoprotein promoter/enhancers affect both hepatocytes and oval cells.

Matthews VB, Rose-John S, Yeoh GC.

Hepatology. 2004 Sep;40(3):759; author reply 760. No abstract available.

PMID:
15349917

Supplemental Content

Loading ...
Support Center